CPIG
ALXN

Chicago Partners Investment Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Chicago Partners Investment Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-416
Closed -$47K – 1019
2018
Q3 		$47K Hold
416
– – 0.01% 528
2018
Q2 		$52K Buy
416
+301
+262% +$35.2K 0.01% 479
2018
Q1 		$13K Hold
115
– – ﹤0.01% 734
2017
Q4 		$14K Hold
115
– – ﹤0.01% 693
2017
Q3 		$16K Hold
115
– – ﹤0.01% 689
2017
Q2 		$14K Buy
+115
New +$13.4K ﹤0.01% 558

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chicago Partners Investment Group's ALXN Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Alexion Pharmaceuticals (ALXN) in Q4 2018, closing a stake of 416 shares — an estimated $47K sold.

Chicago Partners Investment Group first reported a position in ALXN in Q2 2017 and held it in 6 quarters. The position peaked at $52K in Q2 2018. 608 funds tracked by Wall St. Rank hold ALXN as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Alexion Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 416 Alexion Pharmaceuticals shares in Q4 2018, an estimated $47K.
  • Chicago Partners Investment Group first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 6 quarters.
  • Chicago Partners Investment Group's Alexion Pharmaceuticals position peaked at $52K in Q2 2018.
  • 608 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.